Iradukunda Gad patrick,MSc

Regulatory Specialist @RwandaFDA, Commonwealth Almuni, MSc in Clinical Trials @LSHTM Alumni, PhD student @Charité & Researcher

[Iradukunda Gad patrick,MSc @Patrickgadx]

2024 in Review: A Year of Growth, Learning, and Milestones.

More at LinkedIn:
https://t.co/nv0p2YMLsz

[Rwanda Biomedical Centre @RBCRwanda]

🚨Are you a student passionate about Malaria control and elimination?🚨

Rwanda Biomedical Centre invites interested and motivated Master's students to join the Malaria Molecular Surveillance (MMS) Project, an innovative national surveillance and capacity-strengthening initiative funded by the Gates Foundation.

Through this three-year project, RBC is establishing a National Malaria Molecular Surveillance Platform and a National Malaria Reference Genomics Laboratory to strengthen real-time detection and monitoring of antimalarial drug resistance and diagnostic resistance markers.

For more information and application details, please visit the link below
👉🏿📎: https://t.co/VwreTsolHi

[Rwanda Biomedical Centre @RBCRwanda]

DG @CMuvunyi was appointed as a Board Member of the European & Developing Countries Clinical Trials Partnership (EDCTP) Association, a partnership between European and sub-Saharan African countries advancing clinical research and innovation to combat poverty-related infectious diseases.

His appointment reflects #Rwanda's growing leadership in global health research. We look forward to strengthening partnerships, advancing innovation, and improving health outcomes across #Africa.

Congratulations to all the newly appointed Board Members!

[Centre of Excellence for Long-acting Therapeutics @CELTLiverpool]

🌟LAST WEEKS OF EARLY BIRD TICKETS

LA-GLOBAL has early bird pricing available until 22 July

We wanted to make sure this offer existed beyond the abstract submission deadline (8 July), but it's open now for anyone who wants to take advantage
https://t.co/KELb6H3UFI
#LAGLOBAL

[Raffaella Ravinetto @RRavinetto]

Join the Centre of Excellence for Pharmacovigilance in Southern Africa webinar, 6 July, 18h00 SAST: Risk Communication in #Pharmacovigilance: "Lessons from #Vaccine Safety Communication in a Complex Information Environment"
P Bahri & @HannelieMeyer #CEPSA
https://t.co/S3TLAHaAkF

[Raffaella Ravinetto @RRavinetto]

Our review shows a urgent need to expand #vaccine #access along the migratory cycle to/in #Europe; but protecting #confidentiality is essential for #trust and reducing #legal risks. @SalehAljadeeah
@VeroWirtz @AnilPayedimarr @ITMantwerp #migrants #equity
https://t.co/r5ecVPM7Qp

[Rwanda Food and Drugs Authority @RwandaFDA]

The Director General also conducted site visits to leading pharmaceutical manufacturing facilities in Egypt, including Gypto Pharma, Minapharm Pharmaceuticals, and Utopia Pharm.

The visits provided valuable insights into advanced pharmaceutical manufacturing processes and innovative technologies that support the production of safe, effective, and high-quality medicines.

These engagements reaffirm Rwanda FDA’s commitment to advancing pharmaceutical security and regulatory excellence, while supporting Rwanda’s vision of transitioning from a medicine-importing nation to a regional hub for pharmaceutical production.

[Rwanda Food and Drugs Authority @RwandaFDA]

On the sidelines of the Africa Health ExCon 2026, the Director General engaged with Board Members of the Chamber of Pharmaceutical Industry, pharmaceutical manufacturers, and industry leaders to strengthen collaboration and explore opportunities for local manufacturing in Rwanda.

[Rwanda Food and Drugs Authority @RwandaFDA]

This week, the Director General of Rwanda FDA, Prof. @emilebienvenu, participated in the African Health Exhibition and Conference (#AfricaHealthExCon2026) in Egypt and held a series of engagements aimed at strengthening regulatory cooperation and advancing pharmaceutical development.

During the visit, the Director General held bilateral discussions with Dr. Ali El-Ghamrawy, Chairman of the Egyptian Drug Authority (EDA), on priority areas for implementing the Memorandum of Understanding signed between Rwanda FDA and EDA in August 2024, as well as the Joint Recognition Framework for Medicines signed in January 2026.

The visit also included a tour of EDA laboratories to gain insights into regulatory and quality control systems and explore opportunities for enhanced technical collaboration.

[Centre of Excellence for Long-acting Therapeutics @CELTLiverpool]

The next Community of Practice webinar is led by its academic lead, Dr @aeolagunju
🌟Designing for the long haul: Lessons for safety studies of long-acting therapeutics from pregnancy through childhood
📆 25 June 2026
⏰ 4-5.30pm (BST)
📍 Online
💵 Free
🎟️https://t.co/8vd0p20xnm

[Global Health EDCTP3 @EDCTP3]

🗣️ At the @ITMantwerp symposium 'Conversations for Change: Shaping the Future of Essential Medicines':

@EDCTP3's Executive Director, Michael Makanga, called for stronger partnerships between researchers, governments and industry to accelerate child-friendly medicines.

[Raffaella Ravinetto @RRavinetto]

@WHO alert: #falsified JAKAVI (#ruxolitinib) found in Iran, Russia, Turkey. This is criminal, and may pose significant risks to #patient health. But also lack of access do: people in need should have #access to #cancer medicines via #HealthSystems
https://t.co/Hq8xO1ANwX

[Centre of Excellence for Long-acting Therapeutics @CELTLiverpool]

Our 'Manufacturing capability' goal is to facilitate development and manufacture of LATs globally focusing on LMICs.
We will:
- Assess CMO capability
- Identify stakeholders with capabilities to manufacture LATs
- Establish an open access resource.
https://t.co/fURSKJVDA8

[Presidency | Rwanda @UrugwiroVillage]

President Kagame also welcomed Hon. Shirley Botchwey, Secretary-General of the Commonwealth @SGCommonwealth, who is in Rwanda on a working visit. They held constructive discussions on strengthening cooperation between Rwanda and the Commonwealth, and the forthcoming CHOGM 2026.

[Raffaella Ravinetto @RRavinetto]

On 13 June we came together with @TheLancet Commission, to highlight knowledge gaps & chances to boost evidence, & craft recommendations to improve #equitable #access to #essential #medicines. @VeroWirtz @ITMantwerp
https://t.co/zkoctlKy8c

[Hans Kluge @hans_kluge]

Innovation in medicines without access cannot fulfil its promise. Access without innovation cannot meet future needs. We need both.

This was my key message today as I welcomed partners to the Access to Novel Medicines Platform (NMP) Stakeholder Meeting at UN City in Copenhagen.

Endorsed by all WHO/Europe Member States, the NMP has become a unique space for trust, solidarity and practical cooperation.

This progress has been possible because Member States and partners have invested leadership, expertise and trust. But looking ahead, we need sustained support. If we believe that collaborative approaches are part of the solution to access challenges, then we must be prepared to continue investing in them.

My sincere thanks to all those contributing to the Platform, and especially to the Austrian National Public Health Institute, GÖG, for its generous support to the Platform and its Secretariat.

One concrete outcome of this work is a new WHO/Europe policy framework on managed entry agreements. It can help countries navigate difficult decisions on high-cost medicines while keeping access, transparency and sustainability in focus: https://t.co/3d27waJghb

[Rwanda Biomedical Centre @RBCRwanda]

Ese wamenye ko ya marushanwa ya #KigaliInternationalPeaceMarathon yageze? !♀️🏃♂️

Burya siporo yo kwiruka irenze gusiganwa gusa no guhatanira ibihembo!
Buri ntambwe utera ifite agaciro ku buzima bwawe.

Dore akamaro ka siporo yo kwiruka:

✅ Bifasha umutima gukora neza,
✅ Bifasha kuzibura no gukomeza imitsi itembereza amaraso,
✅ Bigabanya ibyago byo kurwara indwara zitandura,
✅ Byongera imbaraga n'ubudahangarwa z'umubiri,
✅ Bifasha umuntu kubungabunga ubuzima bwo mu mutwe.

Tegura umwenda wawe wa siporo tuzahurire muri #KIPM2026.

#SiporoNiUbuzima

[Iradukunda Gad patrick,MSc @Patrickgadx]

Privileged to be part of the 6th @ITMantwerp Short Course on Pharmaceutical Policies in Health Systems. Prof. @VeroWirtz's lecture was truly enlightening, providing valuable insights into the @WHO Essential Medicines selection process and the rich history behind EML. TBC...

[Centre of Excellence for Long-acting Therapeutics @CELTLiverpool]

📣PhD studentship
Design and Development of Ultra‑Long‑Acting Injectable Depot Technologies for Chronic Viral Infection Therapy
Supervisors: Profs Sheng Qi & Andrew Owen
Background: Chemistry, Chemical Engineering, Materials Science, Biomedical Engineering
https://t.co/dJXW6C0Qhh

[Oswald Oswakim @oswaki]

Audio nziza 100% kuko amajwi agerekeranije neza, ubutumwa bwiza 100%...

ARIKO: Ibya video byo ndabona ntazi! Imyambarire, imibyinire 🤐

Padiri @R_CyizaEdmond_M, mpugura!

[Rwanda Food and Drugs Authority @RwandaFDA]

Today, the Director General of Rwanda FDA, Prof. @emilebienvenu, met with a World Bank delegation led by Dr Ronald Mutasa, Practice Manager for Health, Nutrition and Population for Eastern and Southern Africa.
Discussions focused on exploring areas for further collaboration.